Isolation and characterization of cross-neutralizing coronavirus antibodies from COVID-19+ subjects

SARS-CoV-2 is one of three coronaviruses that have crossed the animal-to-human barrier and caused widespread disease in the past two decades. The development of a universal human coronavirus vaccine could prevent future pandemics. We characterize 198 antibodies isolated from four COVID-19+ subjects...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Cell Rep
Asıl Yazarlar: Jennewein, Madeleine F., MacCamy, Anna J., Akins, Nicholas R., Feng, Junli, Homad, Leah J., Hurlburt, Nicholas K., Seydoux, Emilie, Wan, Yu-Hsin, Stuart, Andrew B., Edara, Venkata Viswanadh, Floyd, Katharine, Vanderheiden, Abigail, Mascola, John R., Doria-Rose, Nicole, Wang, Lingshu, Yang, Eun Sung, Chu, Helen Y., Torres, Jonathan L., Ozorowski, Gabriel, Ward, Andrew B., Whaley, Rachael E., Cohen, Kristen W., Pancera, Marie, McElrath, M. Juliana, Englund, Janet A., Finzi, Andrés, Suthar, Mehul S., McGuire, Andrew T., Stamatatos, Leonidas
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Cell Press 2021
Konular:
Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC8216847/
https://ncbi.nlm.nih.gov/pubmed/34237283
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.celrep.2021.109353
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller